1.上海中医药大学附属曙光医院肿瘤科,上海中医药大学附属曙光医院中西医结合肿瘤研究所(上海 201203)
2.上海市宝山区中西医结合医院肿瘤科(上海 201203)
3.上海中医药大学中西医结合研究院(上海 201203)
刘宁宁,男,博士,副主任医师,主要从事中西医结合防治恶性肿瘤的临床和基础研究工作
杨柳,博士,副主任医师;E-mail:bsyykyc@shutcm.edu.cn
李琦,教授,主任医师,博士研究生导师,博士后合作导师;E-mail:qili@shutcm.edu.cn。
扫 描 看 全 文
刘宁宁, 杨越, 贾茹, 等. 补肾解毒方联合姑息化疗对晚期结直肠癌患者癌因性疲乏的影响[J]. 上海中医药杂志, 2021,55(7):59-63.
Ningning LIU, Yue YANG, Ru JIA, et al. Effect of Bushen Jiedu Recipe combined with palliative chemotherapy on cancer-related fatigue in patients with advanced colorectal cancer[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(7):59-63.
刘宁宁, 杨越, 贾茹, 等. 补肾解毒方联合姑息化疗对晚期结直肠癌患者癌因性疲乏的影响[J]. 上海中医药杂志, 2021,55(7):59-63. DOI: 10.16305/j.1007-1334.2021.2010100.
Ningning LIU, Yue YANG, Ru JIA, et al. Effect of Bushen Jiedu Recipe combined with palliative chemotherapy on cancer-related fatigue in patients with advanced colorectal cancer[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(7):59-63. DOI: 10.16305/j.1007-1334.2021.2010100.
目的,2,观察补肾解毒方联合姑息化疗对晚期结直肠癌患者癌因性疲乏的影响。,方法,2,采用前瞻、随机、双盲、安慰剂平行对照的试验设计方法,将72例晚期结直肠癌癌因性疲乏患者随机分为治疗组、对照组,每组36例。对照组采用姑息化疗联合补肾解毒方安慰剂治疗,治疗组采用姑息化疗联合补肾解毒方治疗,两组均持续治疗6个化疗周期或至疾病进展。比较两组Piper疲乏量表及简易疲乏量表中国版(BFI-C)评分的变化情况,观察、记录不良反应的发生情况。,结果,2,①治疗组、对照组各脱落4例,最终完成试验者64例,治疗组、对照组各32例。②治疗前后组内比较,两组Piper疲乏量表各维度(行为疲乏、情感疲乏、躯体感觉疲乏、认知情绪疲乏)评分及量表总分差异均有统计学意义(,P,<,0.05);组间治疗后比较,治疗组Piper疲乏量表各维度评分及量表总分低于对照组(,P,<,0.05)。③治疗前后组内比较,治疗组BFI-C量表中的现疲乏程度、24 h疲乏程度、24 h最严重疲乏程度、对生活的影响(一般活动、情绪、行走、工作、与他人关系、生活乐趣)评分及总分差异均有统计学意义(,P,<,0.05),对照组仅24 h最严重疲乏程度、影响一般活动、影响情绪评分差异有统计学意义(,P,<,0.05);组间治疗后比较,治疗组BFI-C量表各项评分及总分均低于对照组(,P,<,0.05)。④组间不良反应发生情况比较,差异无统计学意义(,P,>,0.05),且均以Ⅰ度、Ⅱ度为主。,结论,2,补肾解毒方联合姑息化疗可明显减轻晚期结直肠癌患者癌因性疲乏程度,且安全性良好。
Objective,2,To observe the effect of Bushen Jiedu Recipe combined with palliative chemotherapy on cancer-related fatigue (CRF) in patients with advanced colorectal cancer (ACC).,Methods,2,In a prospective, randomized, double-blind, placebo-controlled trial design, 72 ACC patients with cancer-related fatigue were randomly divided into treatment group (,n,=36) and control group (,n,=36). The control group was administered with palliative chemotherapy combined with Bushen Jiedu Recipe placebo, while the treatment group was administered with palliative chemotherapy combined with Bushen Jiedu Recipe. The treatment lasted until the expiration of 6 chemotherapy cycles or the disease progression. The score changes of the Piper Fatigue Scale (PFS) and a Chinese version of the Brief Fatigue Inventory (BFI-C) were compared between the two groups, and the incidence of adverse reactions was observed and recorded.,Results,2,①The treatment group and the control group each shed 4 cases, and the remaining 64 subjects completed the trial, 32 cases in the treatment group and 32 cases in the control group. ②The intra-group comparison before and after treatment showed that there were significant differences in the scores of each dimension (behavioral fatigue, affective fatigue, somatosensory fatigue, cognitive emotional fatigue) and the total scores of PFS between the two groups (,P,<,0.05). After treatment, the scores of each dimension and the total scores of PFS in the treatment group were lower than those in control group (,P,<,0.05). ③According to the intra-group comparison before and after treatment, the BFI-C scores of fatigue now, usual fatigue at 24 hours, worst fatigue at 24 hours, impact on life (general activities, mood, walking, normal work, relations with other people, enjoyment of life) and the total scores differed significantly in the treatment group (,P,<,0.05), while in the control group, only differences in the BFI-C scores of worst fatigue at 24 hours, impact on general activities and mood were statistically significant (,P,<,0.05). After treatment, the scores of each dimension and total scores of BFI-C in the treatment group were lower than those in the control group (,P,<,0.05). ④There was no significant difference in the incidence of adverse reactions between groups (,P,>,0.05), and major adverse reactions were of grade Ⅰ and Ⅱ.,Conclusion,2,Bushen Jiedu Recipe combined with palliative chemotherapy can significantly reduce the serverity of cancer-related fatigue in patients with advanced colorectal cancer with good safety.
结直肠癌晚期癌因性疲乏化疗补肾解毒方
colorectal canceradvanced stagecancer-related fatiguechemotherapyBushen Jiedu Recipe
HENLEY S J, WARD E M, SCOTT S, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics[J]. Cancer, 2020, 126(10): 2225-2249.
CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
JIA R, LIU N, CAI G, et al. Effect of PRM1201 combined with adjuvant chemotherapy on preventing recurrence and metastasis of stage Ⅲ colon cancer: A randomized, double-blind, placebo-controlled clinical trial[J/OL]. Front Oncol, 2021, 11: 618793[2020-09-30]. https://pubmed.ncbi.nlm.nih.gov/33747930/https://pubmed.ncbi.nlm.nih.gov/33747930/.
中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2015版)[J]. 中华胃肠外科杂志,2015, 18(10): 961-973.
刘荫华,姚宏伟,周斌,等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J]. 中国实用外科杂志,2017, 37(1): 6-9.
BERGER A M, MOONEY K, ALVAREZ-PEREZ A, et al. Cancer-related fatigue, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(8): 1012-1039.
国家中医药管理局. 中医病证诊断疗效标准:ZY/T 001.1~001.9—94[S]. 南京:南京大学出版社,1994: 33-56.
国家药品监督管理局.《中药新药临床研究指导原则(试行)》[J].北京:中国医药科技出版社,2002.
詹天成,顾晋. NCCN 2016 VI版直肠癌诊治指南更新及其解读[J]. 实用肿瘤杂志,2016, 31(4): 291-295.
EISENHAUER E A, VERWEIJ J, EISENHAUER E A, et al. 11 New response evaluation criteria in solid tumors: RECIST GUIDELINE VERSION 1.1[J]. Ejc Supplements, 2009, 7(2): 5.
MENDOZA T R, WANG X S, CLEELAND C S, et al. The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory[J]. Cancer, 1999, 85(5): 1186-1196.
PIPER B F, DIBBLE S L, DODD M J. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer[J]. Oncol Nurs Forum, 1998, 25(4): 677-684.
皋文君,刘砚燕,袁长蓉. 国际肿瘤化疗药物不良反应评价系统—通用不良反应术语标准4.0版[J]. 肿瘤,2012, 32(2): 142-144.
BORNEMAN T, KOCZYWAS M, SUN V, et al. Effectiveness of a clinical intervention to eliminate barriers to pain and fatigue management in oncology[J]. J Palliat Med, 2011, 14(2): 197-205.
MAUGHAN T S, JAMES R D, KERR D J. Comparison of survival, palliation,and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial[J]. Lancet, 2000, 359(9317): 1555-1563.
STASI R, ABRIANI L, BECCAGLIA P, et al. Cancer-related fatigue: evolving concepts in evaluation and treatment[J]. Cancer, 2003, 98(9): 1786-1801.
金晓燕,雷虹,胡美华. 结直肠癌患者术后化疗期间癌因性疲乏与疾病不确定感的相关性分析[J]. 护理管理杂志,2011, 11(1): 3-5.
谢晓冬,张潇宇. 癌因性疲乏最新进展——NCCN(2018版)癌因性疲乏指南解读[J]. 中国肿瘤临床,2018, 45(16): 817-820.
苏婉,王中奇,邓海滨,等. 抗瘤减毒方联合参芪扶正注射液改善中晚期非小细胞肺癌患者癌因性疲乏的疗效观察[J]. 上海中医药杂志,2019, 53(5): 53-56.
刘畅,赵晓珍,王中奇,等. 肺岩宁方联合抗瘤增效方对中晚期肺腺癌患者化疗后癌因性疲乏、免疫功能及肿瘤标志物影响的临床研究[J]. 上海中医药杂志,2019, 53(6): 49-53.
0
浏览量
427
下载量
0
CSCD
10
CNKI被引量
关联资源
相关文章
相关作者
相关机构